Silicon valley tech entrepreneur. CEO of M10.
Started COVID-19 Early Treatment Fund because repurposed drugs are fastest, cheapest way to end the pandemic and the government wasn’t funding the top drugs/researchers.
We funded the fluvoxamine trials. Taken early enough fluvoxamine can help prevent hospitalization and long haul COVID (PACS). Close to 100% effect size in clinical use.